Binding appears specific for this class of compound since no binding was seen with the unrelated compounds, tetracycline, ampicillin, ATP, BSA, and the PEG12 biotin linker.
Immunofluorescence staining and flow cytometry analysis with the FITC-labeled MAb and scFv demonstrated preserved immunoreactivity by binding to CA125 antigen expressed on the membrane of NIH OVCAR-3 cells, aNIH OVCAR-3ng was seen with SKOV3 cells (Figure 2andB, C).
No specific binding was seen with Ab4L linear at any concentration tested (Figure 3C).
No epithelial binding was seen with unspecific human IgG antibodies or FITC-labeled dextran used as controls (data not shown).
Diminished binding was seen with cold competitive oligonucleotides, demonstrating that binding was specific (Figure 3F, lane 3).
The results show that the proteins LipL32, Lp29, Lp49, LipL40, MLP36, rLIC10494, rLIC12730 and rLIC12238 were interacting with PLG, while no binding was seen with Lsa63, Lsa27, rLIC10509, MPL21, MPL17, rLIC12730 and rLIC12922 (Fig. 3A).
Similar binding is seen with mouse, guinea pig, and chicken PR8 immune seras (Table 1 source data 1).
Whereas Ki values for wt and mutant hRFCs were essentially identical for lometrexol, PT523, ZD9331 and edatrexate, statistically significant differences in binding were seen with other substrates.
Co-immunoprecipitation experiments from Hela cells transfected with GFP-BICDR-1 showed that BICDR-1 precipitates the major dynein/dynactin subunits, whereas no binding is seen with control GFP.
Field-isolate studies have found no statistically significant association between ICAM1 binding and severe malaria in Africa (Refs 30, 69, 70), although increased binding was seen in isolates from patients with clinical malaria (severe and uncomplicated) compared with asymptomatic individuals (Ref. 30).
Optimal binding was seen when the yeast cells were contacted with jute fabric treated with 2% polyethylenimine.
